The Proof with Simon Hill cover image

Preventing and treating cardiovascular disease (Lipid Series - Part 3) | Dr Thomas Dayspring

The Proof with Simon Hill

00:00

The Different Drug Classes That Came Onto the Market in 2001

Zetia came on the market just 2001 I believe was the cholesterol absorption blocker is that a mime that interferes with the function of that sterile influx transporter niemann pixc1 like one so less cholesterol gets pulled into the enterocyte. There's perhaps a minuscule risk of gallstones with that drug too but as long as it doesn't progress beyond threefold you're more than fine to keep the and there's also a theory that these drugs would be one of the thirties to prevent fatty liver down the road although there's no study supported there's animal studies supporting it but no human studies yetso who knows?

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app